Evidence map›Paper›PMID 31596022›Full record

ArticleTraffic (Copenhagen, Denmark)2020

The challenge of personalized cell biology: The example of microvillus inclusion disease.

James R Goldenring

Open access · bronzeAbstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

James R GoldenringDepartment of Surgery and Cell and Developmental Biology, and the Epithelial Biology Center, Vanderbilt University Medical Center, and the Nashville VA Medical Center, Nashville, Tennessee.ORCID 0000-0002-7833-2940
Nashville VA Medical Center · US

Funding

COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepositoryRC2DK118640 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI James Richard Goldenring, Izumi Kaji · 2019 to 2026
$14.8M
SMALL GTP BINDING PROTEINS IN GASTROINTESTINAL MUCOSAR01DK048370 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOLDENRING, JAMES RICHARD · 1994 to 2025
$10.1M
Molecular characteristics of the apical recycling systemR01DK070856 · NIDDK · VANDERBILT UNIVERSITY · PI GOLDENRING, JAMES RICHARD · 2006 to 2014
$3.1M
Generating a Porcine Model for Human Microvillus Inclusion Disease (MVID) by Gene EditingR43DK109820 · NIDDK · RECOMBINETICS, INC. · PI GOLDENRING, JAMES RICHARD, MELKAMU, TAMENE · 2016 to 2016
$395k
NIDDK NIH HHS R01 DK048370NIDDK NIH HHS R01 DK070856NIDDK NIH HHS R01 DK48370NIDDK NIH HHS R01 DK70856NIDDK NIH HHS R43 DK109820NIDDK NIH HHS RC2 DK118640
6 · The paper itself

Abstract

Whole exome sequencing now provides a tool for rapid analysis of patients manifesting congenital diseases. Congenital diarrheal diseases provide a critical example of the challenges of combining identification of genetic mutations responsible for disease with characterization of the cell biological and cell physiological deficits observed in patients. Recent studies exploring the cellular events associated with loss of functional Myosin 5B (MYO5B) have demonstrated the importance of cell biological and physiological analyses to provide a greater understanding of the implications of pathological mutations. Development of enteroids derived from biopsies of patients with complex congenital diarrheal diseases provides a critical resource for evaluation of the cell biological impact of specific monogenic mutations on enterocyte function. The ability to identify putative causative mutations for congenital disease now provides an opportunity to coordinate the efforts of physicians and cell biologists in an effort to provide patients with personalized cell biology analysis to improve patient diagnosis and treatment.

Indexed as

Malabsorption SyndromesMucolipidosesMyosin Type VHumansMicrovilliPrecision MedicineMyosin Type VDGAT1diarrheaenterocytesepitheliaMYO5Bneonateswhole exome sequencing

Identifiers

PMID31596022
PMCPMC7597464
OpenAlexW2979895452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.